Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (10394)	2/11/2004 3:37:02 PM
From: zeta1961	Read Replies (1) \| Respond to of 52153

<<WSJ on drug development, then and now:>> Thanks Peter for sharing...very touching personal and professional history of Sternbach and the drug industry...amazing he's still alive after years of self-clinical trials... I too always tasted a drop of any liquid medicine I gave to the kids to be able to be honest with them, worked very well in establishing trust...best tasting is the liquid motrin! the liquid Digoxin is a pretty pastel green but pungent... Also brought a reminder of Carl Jung's memoir written when he was in in early 80's...he confessed to doing things that worked for his patients that his colleagues would have frowned upon...one lady was bounced from analyst to analyst because at some point in therapy she would stand up and slap the analyst in the face...she was referred to Jung...he recounts that after several sessions, she continued her pattern and stood up, indignant and threatened to slap him..."You can slap me if you want,but I will slap you back," was his response(slight paraphrase)...apparently, she sat back down and never threatened nor slapped him and successfully completed therapy....

To: Biomaven who wrote (10394)	2/11/2004 10:53:16 PM
From: Spekulatius	Read Replies (1) \| Respond to of 52153

The cost of clearing a single drug past today's legal, regulatory and marketplace hurdles has risen to $1.7 billion Interesting article indeed. It illustrates quite colorful how the drug development has changed during the last 40 years. 1.7B$ for a single drug is a mindboggling number. I remember I read in some annual report in 1982 that a drug costs about 100M$ to develop - the cost has gone up 17 fold in 20 years. I understand that regulations are tougher but I cannot help but think of this as a failure of epic dimensions to make medicines available to people. In the end the inflated cost to develop drugs has to be paid by each one of us. I am not even sure whom to blame here - government regulations, the legal situations, drug companies, the FDA or all of the above?